Issue: Volume XXIX, No. 11 - August 8, 2022

Labs Face Powerful and Unwelcome Forces

OVER THE PAST 25 YEARS, THERE HAS BEEN WIDESPREAD RECOGNITION THAT HEALTHCARE IN THE UNITED STATES is on an unsustainable path. The obvious argument was that year-over-year increases in healthcare costs would eventually overcome the ability of employers (private health plans) and the government (Medicare and Medicaid) to pay the bill.  Yet, 25 years after …

Labs Face Powerful and Unwelcome Forces Read More »

News and Insights from AACC Meeting in Chicago

CEO SUMMARY: There was plenty of positive energy last month when the 72nd Annual Scientific Meeting and Exhibition of the American Association of Clinical Chemistry (AACC) took place in Chicago. Attendees seemed pleased to be gathering and networking in person. However, there was recognition that the acute staffing shortage, combined with increasing inflation and deteriorating …

News and Insights from AACC Meeting in Chicago Read More »

Tough Times Ahead for Hospitals and Their Labs

CEO SUMMARY: These are challenging times for the nation’s hospitals, health systems, and clinical labs. A perfect storm involving unprecedented shortages of lab staff, nurses, and other professionals with inflation-fueled cost increases and deteriorating hospital finances was a major topic of discussion by lab leaders and lab vendors at last month’s annual meeting of the …

Tough Times Ahead for Hospitals and Their Labs Read More »

Hospital Lab Outreach Taps On-Demand Testing

CEO SUMMARY: In this case study, clinical laboratory managers from Bryan Health in Nebraska explain how they expanded their lab outreach program to include direct-to-consumer tests. The project involved researching what tests were most appropriate without the need for a physician’s order and enlisting the help of various business departments within the health system.  FINDING …

Hospital Lab Outreach Taps On-Demand Testing Read More »

Coverage, Reimbursement Still Difficult for New Lab Tests

CEO SUMMARY: Bringing a new proprietary diagnostic test to market is an arduous process. It takes patience and planning to complete the journey from test development to payer reimbursement. This slow process stems from the fact that the healthcare reimbursement system is fragmented, with the three main segments being Medicare, Medicaid, and private payers, each …

Coverage, Reimbursement Still Difficult for New Lab Tests Read More »

;